Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial
Jeffrey A How, Shannon N Westin, Melissa Pham, Barrett Lawson, Minxing Chen, Nidhi Tandon, Ying Yuan, Rugang Zhang, Amir A Jazaeri, Anil K Sood, Michaela Onstad Grinsfelder, Kathleen M Schmeler, David J Vining, Samantha M Fix, Yibo Dai, Mikayla B Bowen, Karen H Lu, Melinda S Yates, Russell Broaddus, · 2026
Read Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial by Jeffrey A How, Shannon N Westin, Melissa Pham, Barrett Lawson, Minxing Chen, Nidhi Tandon, Ying Yuan, Rugang Zhang, Amir A Jazaeri, Anil K Sood, Michaela Onstad Grinsfelder, Kathleen M Schmeler, David J Vining, Samantha M Fix, Yibo Dai, Mikayla B Bowen, Karen H Lu, Melinda S Yates, Russell Broaddus, (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631232.txt.
Description
How and co-authors run a phase two trial adding a third drug to a two-drug hormone-based regimen for endometrial cancer that has come back. Patients were randomized between everolimus plus letrozole alone and the same pair with ribociclib added. Their 2026 report covers survival, response rates, and side effects for the two arms.
Overall, the added drug changed little: progression-free and overall survival overlapped, and dropouts for toxicity were similar. Two subgroups broke the pattern. In patients who had prior hormone therapy, the response rate jumped to about sixty-two percent with the third drug, against zero without it. And within the triple-drug arm, tumors carrying a CTNNB1 mutation fared far better on both survival measures. The authors conclude the combination suits selected patients rather than all comers, with mutation status as a guide.
Catalog record
| CREATOR | Jeffrey A How, Shannon N Westin, Melissa Pham, Barrett Lawson, Minxing Chen, Nidhi Tandon, Ying Yuan, Rugang Zhang, Amir A Jazaeri, Anil K Sood, Michaela Onstad Grinsfelder, Kathleen M Schmeler, David J Vining, Samantha M Fix, Yibo Dai, Mikayla B Bowen, Karen H Lu, Melinda S Yates, Russell Broaddus, |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |